England, James T.
Nye, Taylor
Cheung, Verna
Urbach, David R.
Viswabandya, Auro https://orcid.org/0000-0001-9690-4669
Sibai, Hassan
Gupta, Vikas https://orcid.org/0000-0002-1419-8607
Funding for this research was provided by:
The Elizabeth and Tony Comper Foundation
Article History
Received: 29 July 2024
Revised: 28 October 2024
Accepted: 31 October 2024
First Online: 8 November 2024
Competing interests
: JTE, TN, VC, DRU and AV report no conflicts or competing interests to declare. HS has received Honoraria for Consulting or Advisory Role for Novartis, BMS, Gilead Sciences, AbbVie, Jazz, Pfizer. VG has received research funding through his institution and honoraria from Novartis, Abb Vie and and has served on the advisory board of Novartis, Incyte, GSK, BMS-Celgene, Abb Vie, Sierra Oncology, Pfizer and Daichii Sankyo.
: This study has been conducted in accordance with the Tri-Council Policy Statement (TCSP-2) for ethical conduct for research involving humans, and was approved by the University Health Network research ethics board (#21-5954). Written informed consent was obtained from all study subjects.